MedTrace Logo

Respiratory Depression of Remimazolam vs. Propofol for Monitored Anesthesia Care

NCT07076628 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2025-07-22

No results posted yet for this study

Summary

The comparison of incidence of respiratory depression between remimazolam and propofol under monitored anesthesia care for hysteroscopic surgery

Conditions

  • Propofol
  • Remimazolam
  • Hysteroscopic Surgery
  • Respiratory Insufficiency
  • Hemodynamics Instability

Interventions

DRUG

Propofol

Propofol infusion with remifentanil

DRUG

Remimazolam

Remimazolam infusion with remifentanil

Sponsors & Collaborators

  • DongGuk University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-24
Primary Completion
2025-05-30
Completion
2025-05-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07076628 on ClinicalTrials.gov